INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
The post INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023 appeared first on InvestorPlace.
More From InvestorPlace